Recurrent Breast Cancer Terminated Phase 1 / 2 Trials for Romidepsin (DB06176)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01938833Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTreatment